drugset / Trial / NCT00712439

Safety and Efficacy of Gabapentin in Diabetic Peripheral Neuropathy

NCT00712439

Phase 2 Completed 147 enrolled Depomed
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether a new Gabapentin tablet, is safe and effective for the treatment of painful diabetic peripheral neuropathy.

Timeline

Start
2006-04
Primary completion
2006-11
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 3000 mg